Page Contents
Cutaneous lymphoma is often a chronic disease that can be managed for many years, and prognosis (chance of recovery) depends on the specific type, stage and how the disease behaves over time. Some types grow slowly and tend to stay in the skin, while others are more aggressive or may spread to lymph nodes, blood or internal organs.
Cutaneous Lymphoma Care Tailored to You
You and your family are our top priority. At Fred Hutch Cancer Center, we offer comprehensive and compassionate care — personalized to you. You'll have access to the latest treatment options, clinical trials and supportive care services.
Factors that Affect Prognosis
Your outlook is influenced by several key factors:
- The type of cutaneous lymphoma (for example, mycosis fungoides, Sézary syndrome, cutaneous B‑cell lymphomas).
- The stage of disease, including how much of the skin is involved and whether lymph nodes, blood or other organs are affected.
- How fast the lymphoma is growing or changing and how it responds to treatment.
Early‑stage disease that mainly affects limited areas of skin generally has a better outlook than advanced disease that involves many areas of skin or other parts of the body.
Living with a Chronic Condition
Many people with cutaneous lymphoma live with it as a long‑term, manageable condition. Treatment plans often change over time, and it is common to receive more than one type of therapy as the disease or your needs change.
Because the disease can come and go or look different at different times, regular follow‑up visits and skin exams are important. Your care team will watch for changes, adjust treatment as needed and help manage symptoms so you can maintain the best possible quality of life.
Talking with Your Care Team about Survival Rates
Your Fred Hutch team will talk with you about what your diagnosis and stage may mean for your individual outlook, based on your specific type of cutaneous lymphoma, your overall health and how it is responding to treatment. Prognosis numbers are based on groups of people and cannot predict exactly what will happen for any one person, so these conversations focus on your goals, treatment options and what to expect from follow‑up care.